Down-regulation of an established immune response via chemical carcinogen or UVB-altered skin

Y P Chen1, G M Woods, G W Dandie

  • 1Division of Pathology, University of Tasmania, Hobart, Australia.

Insights

Researchers explored down-regulating immune responses using modified skin immunization. Chemical carcinogen-treated skin induced antigen-specific immune suppression, potentially aiding autoimmune disease treatment.

Area of Science:

  • Immunology
  • Dermatology
  • Toxicology

Background:

  • Established immune responses are typically difficult to down-regulate.
  • The skin's immune system plays a critical role in immune regulation.
  • Modulating skin immunity may offer novel therapeutic strategies.

Purpose of the Study:

  • To investigate antigen-specific immune suppression via modified skin immunization.
  • To determine the efficacy of chemical carcinogen- or ultraviolet B (UVB)-treated skin in down-regulating established immune responses.
  • To explore potential applications in treating autoimmune diseases.

Main Methods:

  • Mice were immunized with 2,4,6-trinitrochlorobenzene (TNCB).
  • TNCB-immune mice received antigen through skin treated with 7,12-dimethylbenz(a)anthracene (DMBA) or UVB.
  • Immune responses, including contact sensitivity and antibody production, were measured.

Main Results:

  • DMBA-treated skin followed by TNCB induced antigen-specific reduction in contact sensitivity and antibody production.
  • Spleen cells from DMBA/TNCB-treated donors also reduced immune responses in recipients.
  • UVB-treated skin followed by TNCB reduced contact sensitivity but not antibody production.

Conclusions:

  • Immunization through chemically modified skin can suppress established immune responses.
  • This approach offers a potential new avenue for managing autoimmune conditions.
  • Skin immune system modification presents a promising strategy for immune tolerance induction.

Related Concept Videos

Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...